Cite

HARVARD Citation

    Frontzek, F. et al. (2022). Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma. Therapeutic advances in hematology. p. . [Online]. 
  
Back to record